Epidermal Growth Factor Receptor Antibodies Market Is Expected to Rise at a Remarkable CAGR During 2016 to 2024
EGFR is the primary receptor recognized in a group of receptors and is a cell surface protein that binds to epidermal growth factor.EGFR is a cell membrane growth factor receptor characterized bytyrosine kinase receptor which plays very important role in the control of key cellular transduction pathways in both normal and cancerous cells.EGFR is the first molecular target against which monoclonal antibodies (mAb) have been developed in cancer therapy.
View full press release